Therapeutic Treatment for Benign Prostatic Hyperplasia

<p>The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity and with up to 90% of men in their 80s suffering from BPH to some extent it is imperative that patients are offered the full range of options to manage the disease. </p><p>Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists such as terazosin doxazosin alfuzosin and tamsulosin and the 5-alpha-reductase inhibitors finasteride and dutasteride. Other strategies such as plant-derived medication or watchful waiting are applied to varying extents. </p><p>Derived from the benchmark title on BPH - <em>Textbook</em> <em>of Benign Prostatic Hyperplasia</em> - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.</p>